| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/02/2008 | EP1904110A1 Targeting cells with altered microrna expression |
| 04/02/2008 | EP1904107A2 Use of inhibitors of histone deacetylases in combination with nsaid for the therapy of cancer and/or inflammatory diseases |
| 04/02/2008 | EP1904102A1 Anti-ccr7 receptor antibodies for the treatment of cancer |
| 04/02/2008 | EP1904093A2 Inhibition of the tumorigenic potential of tumor stem cells by lif and bmps |
| 04/02/2008 | EP1904086A2 Treatment of tumors |
| 04/02/2008 | EP1904065A2 Use of dual c-kit/fgfr3 inhibitors for treating multiple myeloma |
| 04/02/2008 | EP1904060A1 Use of phthalocyanine derivates for the non-photodynamic treatment of diseases |
| 04/02/2008 | EP1904057A2 Methods of treatment using hydroquinone ansamycins |
| 04/02/2008 | EP1904052A1 Liquid pharmaceutical formulations of docetaxel |
| 04/02/2008 | EP1904051A1 Bicalutamide adsorbates, process for preparing same, and pharmaceutical compositions thereof |
| 04/02/2008 | EP1904047A2 Apoptosis promoters |
| 04/02/2008 | EP1904045A1 Use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine for treating cancer |
| 04/02/2008 | EP1793817A4 Methods of treating a disorder |
| 04/02/2008 | EP1697384B1 Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
| 04/02/2008 | EP1424898A4 Treatment of cancers by inhalation of stable platinum-containing formulations |
| 04/02/2008 | EP1424889A4 Method for treating lung cancers |
| 04/02/2008 | EP1397153B1 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 04/02/2008 | EP1390027B1 Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof |
| 04/02/2008 | EP1244466B1 ACTIVATION OF THE IMMUNE SYSTEM BY AN NF-kappaB INDUCER AND AN ANTIGEN |
| 04/02/2008 | EP1232147B1 Triazoles as farnesyl transferase inhibitors |
| 04/02/2008 | EP1210357B1 Oligonucleotide n3'-p5' thiophosphoramidates: their synthesis and use |
| 04/02/2008 | EP1009824B1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-kappaB ACTIVATION |
| 04/02/2008 | EP0815245B1 Bioactive il-12 fusion proteins |
| 04/02/2008 | CN101155808A Substituted 1,5-naphthyridine azolidinones as cdk inhibitors |
| 04/02/2008 | CN101155807A Compounds having tie2 (tek) inhibitory activity |
| 04/02/2008 | CN101155800A Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 04/02/2008 | CN101155791A Thiazolidinones for use as inhibitors of polo-like kinase (plk) |
| 04/02/2008 | CN101155786A N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
| 04/02/2008 | CN101155784A Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 04/02/2008 | CN101155782A Potentiator for radiation therapy comprising pyridine derivative as active ingredient |
| 04/02/2008 | CN101155600A Radiotherapy enhancer |
| 04/02/2008 | CN101155595A Antitumor agent and dnase |
| 04/02/2008 | CN101155584A Methods for administering ixabepilone |
| 04/02/2008 | CN101155582A Compositions and methods for treating neoplastic diseases |
| 04/02/2008 | CN101155577A Local treatment of neurofibromas |
| 04/02/2008 | CN101153056A Regrouped anticancer peptide, producing method and application of the same |
| 04/02/2008 | CN101153054A Peptide for treatment of vascellum generation and uses thereof |
| 04/02/2008 | CN101153042A Thienopyrimidine compound and use of the same |
| 04/02/2008 | CN101153041A 1,2,3-triazole 1,3-nitrogen heterocyclic, producing method and application of the same |
| 04/02/2008 | CN101153024A Aryl substituted imidazoline-2-ketones derivant, producing method and uses of the same |
| 04/02/2008 | CN101153023A Tetrahydrochysene isoquinoline derivant, its producing method and uses of the same |
| 04/02/2008 | CN101152575A Application of double-chain small disturbance RNA of PEG10 gene in preparing medicament for treating or preventing liver cancer |
| 04/02/2008 | CN101152565A Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 04/02/2008 | CN101152563A Combination therapy using trefoil peptides |
| 04/02/2008 | CN101152518A Traditional Chinese medicine for treating chemotherapy adverse effect after mammary cancer operation |
| 04/02/2008 | CN101152510A Pharmaceutical composition, preparing method and use the same |
| 04/02/2008 | CN101152433A Traditional Chinese medicine for treating chemotherapy leukocytopenia after mammary cancer operation |
| 04/02/2008 | CN101152422A Numbness-eliminating anticancer wine for treating thyroid carcinoma |
| 04/02/2008 | CN101152408A Pharmaceutical composition having function cancer of the lungs against |
| 04/02/2008 | CN101152360A Traditional Chinese medicine for treating adverse effect of mammary cancer endocrine |
| 04/02/2008 | CN101152282A Traditional Chinese medicine for treating tumefaction of membrum superius after mammary cancer operation |
| 04/02/2008 | CN101152266A Traditional Chinese medicine preparations and use of the same |
| 04/02/2008 | CN101152251A Application of magnolia bark and its active ingredient in preparing medicament for treating tumour stem cell |
| 04/02/2008 | CN101152232A Effective component of atractylodes macrocephala, preparing method and application of the same |
| 04/02/2008 | CN101152227A Effective component of ligusticum wallichii, preparing method and application of the same |
| 04/02/2008 | CN101152210A Application of As*O* combined with TSA in preparing medicament for inducing leukocythemia HL60 cell to convert from portion differentiation to terminal differentiation |
| 04/02/2008 | CN101152209A Application of As*O* combined with TSA in preparing medicament for inducing leukocythemia HL60 cell to convert from portion differentiation to apoptosis |
| 04/02/2008 | CN101152204A Vein drug administration preparations of clofarabine and method for preparing the same |
| 04/02/2008 | CN101152193A Application of 1,3,4-3-O-gallnut acyl-6-O-coffee acyl-beta-D-glucopyranose in preparing antineoplastic medicament |
| 04/02/2008 | CN101152192A Application of 1,3-2-O-gallnut acyl 1-4,6-(S)-HHDP-beta-D-glucopyranose in preparing antineoplastic medicament |
| 04/02/2008 | CN101152185A Use of heterocyclic compounds as scce inhibitors |
| 04/02/2008 | CN101152179A Application of isoniazide as histone deacetylase inhibitors |
| 04/02/2008 | CN101152177A Application of kuh-seng alkaloid in preparing medicament for treating human epigenetic deactivation disease |
| 04/02/2008 | CN101152165A Antineoplastic isoliquirtigenin tablet |
| 04/02/2008 | CN101152160A Oral pharmaceutical formulation containing ibandronate |
| 04/02/2008 | CN101152150A Preparation of paclitaxel carried medicine sustained-release microsphere by supercritical fluid technique |
| 04/02/2008 | CN100378140C Block copolymer reduced in impurity content, polymeric carrier, pharmaceutical preparations in polymeric form and process for preparation of the same |
| 04/02/2008 | CN100378127C Antibodies against insulin-like growth factor I receptor and application thereof |
| 04/02/2008 | CN100378125C Bionic affinity purifying process of interleukin I natural agonist |
| 04/02/2008 | CN100378121C Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 04/02/2008 | CN100378112C Novel carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
| 04/02/2008 | CN100378107C Oxazolo-and-furopyrimidines and their use as medicaments against tumors |
| 04/02/2008 | CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives |
| 04/02/2008 | CN100378073C Dindoly methylane and preparation process thereof |
| 04/02/2008 | CN100377712C Cucurbitacin lipsome preparation method and formulation |
| 04/02/2008 | CN100377711C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 04/02/2008 | CN100377709C Use of acceptor tyrosine kinases inhibitor and related detecting method |
| 04/02/2008 | CN100377708C Method for preparing tablet of hydroxy camptothecin and application of oral application |
| 04/02/2008 | CN100377706C A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 04/02/2008 | CN100377704C Liposomal formulations |
| 04/01/2008 | US7351841 Heterocyclic compounds and thrombopoietin receptor activators |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351807 Cyanine-sulfenates for dual phototherapy |
| 04/01/2008 | US7351790 Peptide-based compounds |
| 04/01/2008 | US7351737 4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity |
| 04/01/2008 | US7351735 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias |
| 04/01/2008 | US7351730 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 04/01/2008 | US7351729 JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers |
| 04/01/2008 | US7351725 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection |
| 04/01/2008 | US7351714 viral infections; lung tumor and gastric cancer; 7-2-(2-aminophenyldithio)phenyliminomethylcamptothecin |
| 04/01/2008 | US7351712 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one |
| 04/01/2008 | US7351711 Tricyclic indanyls as integrin inhibitors |
| 04/01/2008 | US7351702 Caspase inhibitors and uses thereof |
| 04/01/2008 | US7351701 Therapeutic compounds |
| 04/01/2008 | US7351697 Tumor-specific vector for gene therapy |
| 04/01/2008 | US7351694 Diagnosis of prostate cancer; genetic engineered protein |
| 04/01/2008 | US7351554 Administering vaccine, native E7 protein, inactive fragment of the immunosuppressive and/or angiogenic native E7 protein;a DNA molecule encoding immunosuppressive and/or angiogenic native E7 protein inactivated by mutation; adjuvant of mucosal immunity |
| 04/01/2008 | US7351531 Molecules capable of binding to telomere and the like and method with the use of the same |
| 04/01/2008 | US7351431 Dissolved cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(alkanoyloxy)]platinum(II) in 2-methyl-2-propanol; stabile, easily handled injection; fine, homogenous suspension; controlled particle size distribution |
| 04/01/2008 | US7351409 Tumor antigens and CTL clones isolated by a novel procedure |